Inhibitory effects of melatonin on the development of 17-β-estradiol induced prolactinoma in relation to plasma prolactin and peroxidative lipid contents

( views:, downloads: )
Author:
()
()
()
()
()
Journal Title:
ACTA PHYSIOLOGICA SINICA
Issue:
Volume 53, Issue 03, 2001
DOI:
Key Word:

Abstract:

  • [1]Blask DE. Melatonin in oncology. In: Yu HS, Reiter RJ eds. Melatonin Biosynthesis, Physiological Effects, and Clinical Applications. Boca Raton: CRC Press, 1993, 447~459.
  • [2]Panzer A, Viljoen M. The validity of melatonin as an oncostatic agent. J Pineal Res, 1997, 22:184~202.
  • [3]Lincoln GA, Maeda KI. Effects of placing micro-implants of melatonin in the mediovasal hypothalamus and preoptic area on the secretion of prolactin and β-endorphin in rams. J Endocrinol, 1992, 134:437 ~ 448.
  • [4]Xu RK, Guo CH, Huang MY et al. Induction of rat prolactinoma by 17-β-estradiol and its relation to expression of cmyc oncogene. Dev Reprod Biol, 1995, 4:64~69.
  • [5]Wu XM(吴雪梅),Zang R(张荣),Xu RK(许荣焜)al. Effect of 17-β-estradiol on the expression of transforming growth factors in anterior pituitary cells of rats. Bas Med Sci (基础医学与临床),1998,18(5):351~355nese, English abstract).
  • [6]Molis TM, Spriggs LL, Hill SM. Modulation of estrogon receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Mol Endocrinol, 1994, 8:1681~1690.
  • [7]Lloyd RV. Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemica study.Am J Pathol, 1983, 113:198~206.
  • [8]Li .JL(李家林)The plasma peroxidative lipid contents measured by ultraviolet spectroptometry. Chin Circ (中国循环杂志),1989,4:57~61(Chinese).
  • [9]Cao L(高列),(许荣焜),(赵三妹) et al. Inhibitory effects of melatonin on the proliferation of 17-β-estrogen induced pituitary prolactin-secreting tumor cells of the rats in vitro. Bas Med Sci Ciin(基础医学与临床),2001, 21:57~60 (Chinese, English abstract).
  • [10]Lemus-Wilson A, Kelly PA, Blask DE. Melatonin blocks the stimulatory effects of prolactin on human breast cancer cell growth in culture. Br J Cancer, 1995, 72:1435 ~ 1440.
  • [11]Dubocovic ML. Melatonin receptors: Are there multiple subtvpes? Trends Pharmacol Sci, 1995, 16:50~56.
  • [12]Episawa T, Kame S, Lemer MR et al. Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc Natl Acad Sci USA, 1994, 91:6133~6137.
  • [13]Leadem CA, Blask DE. Evidonce of an inhibitory irfluence of the pineal on prolactin in the female rat. Neuroendocrinology, 1981, 33:268~275.
  • [14]Vigue C, Thibault J, Thiery JC et al. Characterization of the short day-induced decrease in median eminence tyrosine hydroxylase sctivity in the ewe: Temporal relationship to the changes in luteinizing hormone and prolactin secretion and short day-like effect of melatonin. Endocrinology, 1997,138:499~506.
  • [15]Alexiuk NAM, Uddin M, Vriend J. Melatonin increases the in situ activity of tyrosine hydroxylase in the mediobaasl hypothalamus of male syrian hamsters. Life Sci, 1996, 59:687~694.
  • [16]Blask DE, Nodelman J, Leadem CA. Preliminary evidence that a dopamine receptor antagonist blocks the prolactin-inhibitory effects of melatonin in anosmic male rats. Experimentia, 1980, 36:1008~1009.
  • [17]Vanece KJ, Klein DC. Mechanism of melatonin signal transduction in the neonatal rat pituitary. Neurochem Int, 1995,27. 273 ~ 278
  • [18](周远征),(许荣焜),(单惠敏)et al. Reconstruction and applicantion of eukaryotic expression plasmid of rat prolactin gene. Chin J Appl Physiol (中国应用生理学报),1998,14:304~311(Chinese, English abstract).
  • [19]Ciccare E. The prolactin receptor existed in the pituitary tumor of human beings. Clin Endocrinol,1995, 42:487~491.
  • [20]Reiter RJ, Poeggeler B, Tan DX et al. Antioxidant capacity of melatonin: a novel action not requiring receptor. Neuroendocrinol Lett, 1993, 15:103~ 116.
  • [21]Cavalieri EL, Stack DE, Devanesan PD et al. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initistors. Proc Natl Acad Sci USA, 1997, 94:10937~ 10942.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn